Latest News
Unit volumes tell the story of which EV start-up can survive.
Via The Motley Fool · October 4, 2026
IonQ and Alphabet are two completely different investments.
Via The Motley Fool · October 4, 2026
Rafael (NYSE:RFL) reported top-line results from its pivotal Phase III TransportNPC study evaluating Trappsol Cyclo for Niemann-Pick Disease Type C, a rare, progressive genetic disorder. The company said it remains on track to submit a New Drug Application to the U.S. Food and Drug Administration in
Via MarketBeat · October 4, 2026
Micron's revenue surged 432% over two years while Qualcomm's declined, widening a gap that raises questions about sector dynamics and competitive positioning.
Via The Motley Fool · October 4, 2026
Cameco's stock has fallen from $134 to $85, but that drop could be an opportunity for investors looking to invest in nuclear power.
Via The Motley Fool · October 4, 2026
XPH delivered 19% higher returns over five years despite half the volatility. XBI's 165 holdings offer broader exposure but with a 53% maximum drawdown.
Via The Motley Fool · October 4, 2026
Inventiva (NASDAQ:IVA) said it expects to report top-line results in the fourth quarter of 2026 from its fully enrolled Phase III NATiV3 trial of lanifibranor in patients with metabolic dysfunction-associated steatohepatitis, or MASH.
Chief Executive Officer Andrew Obenshain said the final patient
Via MarketBeat · October 4, 2026
Nvidia is in command of the AI arms race.
Via The Motley Fool · October 4, 2026
Nokia trades at a steep premium valuation while Verizon generates nearly 13x more net income on a 12.4% margin, a stark contrast in profitability and value.
Via The Motley Fool · October 4, 2026
AI storage needs are accelerating -- and both of these companies are perfectly positioned to benefit.
Via The Motley Fool · October 4, 2026
Howard Hughes (NYSE:HHH) shareholders elected all 11 board nominees, approved the company’s advisory executive-compensation proposal and ratified KPMG as independent auditor for 2026, according to preliminary results announced at the company’s annual meeting.
Executive Chair Bill Ackman said each d
Via MarketBeat · October 4, 2026
The new Federal Reserve chair still has a lot to prove, and political factors are making that harder.
Via The Motley Fool · October 3, 2026
Peoples Bancorp (NASDAQ:PEBO) has agreed to acquire Rockville, Maryland-based Capital Bancorp Inc. in an all-stock transaction valued at approximately $728 million, a deal management described as transformational because it would add scale, national specialty businesses and a more diversified earnin
Via MarketBeat · October 3, 2026
As investors look for ways to diversify, Bitcoin could soar to new highs.
Via The Motley Fool · October 3, 2026
Both brokers keep drawing in new money. But just one of the two stocks is cheap.
Via The Motley Fool · October 3, 2026
Liberty Silver (OTCMKTS:BHLL) outlined plans to combine Bunker Hill and Silver47, a transaction the company said would create a U.S.-focused, multi-asset mining company centered on silver and other strategic metals.
During the presentation, the company said Bunker Hill has entered production at its
Via MarketBeat · October 3, 2026
The AI build-out isn't slowing down anytime soon.
Via The Motley Fool · October 3, 2026
Alphabet trades at a lower valuation multiple despite slower growth, while Meta invests heavily in hardware amid regulatory headwinds.
Via The Motley Fool · October 3, 2026
Sagimet Biosciences (NASDAQ:SGMT) said its licensed partner Ascletis reported positive 52-week results from an open-label extension study of denifanstat, an oral fatty acid synthase, or FASN, inhibitor being evaluated for moderate-to-severe acne vulgaris in China.
The company also outlined plans fo
Via MarketBeat · October 3, 2026
Cramer was a successful hedge fund manager and has been a market pundit on CNBC for decades.
Via The Motley Fool · October 3, 2026
Grindr (NYSE:GRND) said it has agreed to acquire PurposeMed Inc., the parent company of Freddie, a Canadian telehealth provider of HIV pre-exposure prophylaxis, or PrEP, that is expanding in the United States.
Chief Executive Officer George Arison described the transaction as the company’s first ma
Via MarketBeat · October 3, 2026
The streamer's share of TV time keeps slipping. Is its revenue next?
Via The Motley Fool · October 3, 2026
Rising interest rates are unlikely to change the dynamics in the healthcare sector, where people are willing to pay for care.
Via The Motley Fool · October 3, 2026
ASML's momentum has flipped the script — it now outpaces Qualcomm in recent quarters after trailing for years, raising questions about whether this inversion will stick.
Via The Motley Fool · October 3, 2026
The popular AI agent can do your shopping for you as long as you don't shop on Amazon.
Via The Motley Fool · October 3, 2026